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Melioidosis, infection with the Gram negative bacterium Burkholderia pseudomallei, has increasingly been described in Cambodia in recent years [1] [2] [3] [4] [5] [6] . Infection is caused by inoculation, inhalation, or ingestion of B. pseudomallei, an environmental saprophyte 7 . In one single center Cambodian study, melioidosis (defined as growth of B. pseudomallei in any clinical specimen) was lethal in more than half of cases, many of whom had received inappropriate initial antibiotic therapy 2 . The clinical presentation of melioidosis is notoriously variable, but pneumonia and sepsis occur commonly 7 . Sub-acute and chronic forms of melioidosis may be confused with tuberculosis and it is important to distinguish these diseases 8 . B. pseudomallei is resistant to penicillin, ampicillin, first-and second-generation cephalosporins and aminoglycosides 7 . Use of quinolones or third-generation cephalosporins to treat melioidosis is associated with poorer outcomes 9-11 . Thus, many of the first line antimicrobial therapies administered for pneumonia and sepsis do not adequately treat melioidosis. The treatment course for melioidosis is prolonged, requiring initial intensive therapy for at least 10-14 days with intravenous ceftazidime, imipenem, or meropenem, followed by 3-6 months of oral eradication therapy with trimetho- [12] [13] [14] . We hypothesized that the use of selective enrichment broth and Ashdown's medium at Kampong Cham Provincial Hospital would similarly increase the identification of cases of pulmonary melioidosis.
Methods
To compare the use of selective enrichment broth and Ashdown's medium to standard sputum culture at Kampong Cham Provincial Hospital, we performed specific testing for B. pseudomallei on all sputum specimens submitted to the laboratory and accepted for bacterial culture between March 25 and September 30, 2013, following a previously described protocol 12,14 . We chose these dates to include much of the rainy season, when melioidosis is diagnosed more frequently 2 . No data were available on the subjects who provided the sputum specimens although most specimens were submitted from the hospital's tuberculosis screening area or ward. Specimens accepted for culture had fewer than 10 epithelial cells per low power field or moderate to high numbers of polymorphonuclear cells on Gram stain. Specimens were inoculated into selective enrichment broth containing Tryptic Soy Broth 10g, glycerol 40ml, crystal violet 0.1% 5ml, and colistin 50mg per liter of distilled water for two days at 37°C in aerobic conditions. Specimens were then sub-cultured onto Ashdown's medium (Tryptic Soy Broth 10g, agar 15g, glycerol 40ml, crystal violet 0.1% 5ml, neutral red 1% 5ml, and gentamicin 4mg per liter of distilled water) and incubated for four days at 37°C in aerobic conditions. Colonies that grew were tested using the oxidase test; oxidase-positive colonies were tested using a highly sensitive and specific monoclonal antibody-based latex agglutination test for B. pseudomallei 15, 16 . In parallel, as per routine laboratory practice, all sputum specimens were also cultured onto sheep blood, chocolate, and MacConkey agars.
Results
Two hundred and forty one sputum specimens deemed acceptable for culture were received by the laboratory during the study period and tested using the enhanced protocol. B. pseudomallei was isolated from one specimen (0.4%) using standard media and from two specimens (0.8%) using the enhanced protocol. The single specimen positive using standard media was also positive using the enhanced protocol; the enhanced technique therefore detected one additional isolate of B. pseudomallei compared to the standard protocol. In this case, Klebsiella pneumoniae grew on standard media, raising the possibility that overgrowth of K. pneumoniae precluded detection of B. pseudomallei in the absence of selective enrichment broth. Among the 241 sputum specimens collected during the study period, B. pseudomallei accounted for two (1.6%) of the 122 that were culture positive. Other bacteria isolated from the sputum samples during the study period were K. pneumoniae (54), Pseudomonas species (37), Enterobacter species (7), Acinetobacter species (5) 
Conclusions/Discussion
These data confirm that respiratory melioidosis is detected in patients presenting to Kampong Cham Provincial Hospital although the overall number of sputum specimens positive for B. pseudomallei was low. Our rate of detection of B. pseudomallei in sputum samples submitted to the laboratory is similar to a previously published study evaluating the etiology of clinical respiratory infection at this hospital 3 . This study of patients with acute lower respiratory tract infection identified melioidosis in four of 422 (0.9%) patients from the hospital. The diagnosis was determined by culture of B. pseudomallei from sputum or blood at an off-site laboratory.
In light of the small number of specimens positive for B. pseudomallei we could not definitively ascertain an advantage to the routine use of the enhanced sputum testing protocol. However, the ramifications of identification of B. pseudomallei are substantial. Although ceftazidime and imipenem may not be available in Cambodian hospital pharmacies and cost prevents the outside purchase by most patients, mortality from melioidosis is greatly diminished when appropriate antibiotic therapy is instituted 17 . Others have reported a benefit of a similar diagnostic testing strategy. For example, the use of selective enrichment broth and B. pseudomallei selective agar to test 154 respiratory samples in a referral center in Kuala Lumpur identified three cases of B. pseudomallei that were not detected using routine media 18 .
Our results should be interpreted considering the following limitations. First, as with all tests, the selection of patients and indications for sampling are highly likely to influence the results. We unfortunately do not have those important data. Second, the cost of sputum culture may have been prohibitive for many patients, further skewing the population sampled. Third, a relatively small number of sputum specimens were submitted to the laboratory during the six month period. As the hospital microbiology laboratory has only been operational since 2009, this may reflect the established clinical practice of not relying on microbiology data to make treatment decisions. Thus, a number of factors may contribute to the low rates of detection of B. pseudomallei in sputum samples tested in this study; future studies underway aim to address these issues.
We further observed that the majority of sputum specimens came from patients presenting to the hospital's tuberculosis screening area and ward. This suggests that in many cases clinicians may have been considering the diagnosis of tuberculosis. Melioidosis and tuberculosis may be difficult to distinguish clinically 8 and both infections should be considered in patients with chronic symptoms of respiratory infection in Cambodia. However, most respiratory melioidosis is associated with symptoms for less than two months and the mean incubation period in acute melioidosis is nine days 19, 20 . We speculate that sputum from melioidosis patients presenting elsewhere in the hospital with acute clinical syndromes of pneumonia and sepsis may not have been submitted for culture. This may have reduced our rate of detection of melioidosis in this study. Furthermore, this highlights the importance of informing clinicians of the utility of diagnostic microbiology testing, preferably before initiation of treatment.
Several other techniques should also be considered in the diagnosis of pulmonary melioidosis. In conclusion, these data confirm that B. pseudomallei is a respiratory pathogen in Kampong Cham province but show that it is rarely detected in sputum samples submitted to the diagnostic microbiology laboratory at Kampong Cham Provincial Hospital. As a result, our study cannot conclusively determine the utility of an enhanced sputum testing protocol at this site. The benefit of the enhanced testing protocol may be more apparent in patients selected based on risk factors and clinical presentation. Future studies will investigate this possibility. In addition, given the severity of melioidosis and importance of identifying the infection to guide treatment, several other factors should be considered in order to increase detection of the disease. In particular, clinician awareness of the diverse presentations of melioidosis and routine utilization of diagnostic microbiology services for patients presenting with pneumonia and sepsis should be promoted. Author contributions TEW conceived the study. SN, JCMc, EJB, and TEW designed the protocol with the support of CM. SN, JL, and ST carried out the study. SN, JL, and TEW analyzed the data. All authors participated in the generation or revision of the manuscript, and approved the final version.
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The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. northeast). It is also unclear why a selective enrichment technique was used as opposed to direct culture onto solid media, since enrichment culture was not shown significantly to increase the B. pseudomallei isolation rate from sputum compared with plating directly onto Ashdown's medium in a previous study ( ). It might also have been possible to have been more selective about the Wuthiekanun ,1990 et al. samples that were cultured and to have analysed patient characteristics in greater detail, although the majority of samples were thought to have been from patients suspected of having TB, a group in whom it has previously been suggested that testing for melioidosis (using a similar enrichment technique) might be warranted ( ).
Suntornsut
., 2013 et al Although this is a relatively small scale study with relatively unremarkable results, it warrants being in the public domain. Laboratories in melioidosis-endemic areas should still be encouraged to consider looking for in appropriate samples and should conduct their own assessment of the costs and B. pseudomallei benefits of doing so based on local epidemiology.
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Thank you for the helpful comments.
We opted not to perform cost-benefit analyses in light of our small numbers of positive samples and wide confidence intervals around point estimates. We agree that these calculations are important to perform in the future in larger studies.
We chose to use selective broth based on Wuthiekanun V et al, Am J Trop Med Hyg 77(5), 2007, 812-13. This study reported that "a total of 94 of 120 (78%) respiratory secretions were positive for B. pseudomallei, of which 33 (35%) were positive from enrichment broth alone."
Unfortunately we do not have any data on patient characteristics. Our future studies aim to investigate patient characteristics and indications for sampling.
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